Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023908
Filing Date
2022-11-09
Accepted
2022-11-09 16:24:39
Documents
77
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sctl-20220930.htm   iXBRL 10-Q 2179367
2 EX-31.1 sctl-ex31_1.htm EX-31.1 16669
3 EX-31.2 sctl-ex31_2.htm EX-31.2 16647
4 EX-32.1 sctl-ex32_1.htm EX-32.1 10744
  Complete submission text file 0000950170-22-023908.txt   9354971

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sctl-20220930_pre.xml EX-101.PRE 428693
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sctl-20220930.xsd EX-101.SCH 61070
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sctl-20220930_lab.xml EX-101.LAB 580649
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sctl-20220930_def.xml EX-101.DEF 229930
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sctl-20220930_cal.xml EX-101.CAL 47747
71 EXTRACTED XBRL INSTANCE DOCUMENT sctl-20220930_htm.xml XML 1834217
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Societal CDMO, Inc. (Filer) CIK: 0001588972 (see all company filings)

EIN.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 221373041
SIC: 2834 Pharmaceutical Preparations